Anutra Medical adds 1% lidocaine with epinephrine 1:100,000 to product offerings

Anutra Medical is now adding 1% lidocaine with epinephrine 1:100,000 to its product offerings, making this particular concentration of lidocaine more accessible to the dental market.

A study published in the Journal of Oral and Maxillofacial Surgery in October 2017 showed that buffered 1% lidocaine with epinephrine can be as effective as 2% lidocaine with epinephrine for a maxillary field block. (1) This independent study by the University of North Carolina Chapel Hill found that buffering 1% lidocaine with epinephrine 1:100,000 with the Anutra Local Anesthetic Delivery System “[reduced] the pain on injection with a maxillary field block and [resulted] in similar lengths of pulpal anesthesia tested with a cold stimulus,” as compared to 2% lidocaine with epinephrine 1:100,000. (1)

The Anutra Medical Local Anesthetic Delivery System

In other studies conducted in April 2017, the School of Dentistry at the University of North Carolina Chapel Hill found that “mean blood level differences of lidocaine for each patient were significantly lower after nerve block with the buffered drug compared with the nonbuffered agent.” (2)

The new product offering will be available through all of Anutra Medical’s distribution partners, including but not limited to Henry Schein Dental and Benco Dental, during the first quarter of 2018. Anutra is currently accepting orders for the new product offering.

References

1. Warren VT, Fisher AG, Rivera EM, et al. Buffered 1% lidocaine with epinephrine can be as effective as non-buffered 2% lidocaine with epinephrine for maxillary field block. J Oral Maxillofac Surg. 2017;75(7):1363-1366.

2. Phero JA, Nelson B, Davis B, et al. buffered versus non-buffered lidocaine with epinephrine for mandibular nerve block: clinical outcomes. J Oral Maxillofac Surg. 2017;75(4):688-693.

For the most current dental product articles, click here.

For the most current dental headlines, click here.